Larvol Delta - CSTI300-a-novel-5HT-receptor-partial-agonist-with-potential-to-treat-patients-with-irritable-bowel-syndrome-or-carcinoid-syndrome

SMP-100 - Xiling Lab, ConSynance

http://www.ncbi.nlm.nih.gov/pubmed/32102919

Mar 1, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev